Morgan Stanley names UnitedHealth a "Top Pick"

Morgan Stanley is getting more bullish on UnitedHealth Group (UNH) ahead of earnings, upgrading the stock to a Top Pick and assigning a $375price target.

The call signals a shift in the narrative, with key risks around Medicare Advantage, Optum Health, and cost structure starting to ease. The bigger question now is whether UnitedHealth's execution can turn an improving backdrop into real earnings growth.

Morgan Stanley names UNH a "Top Pick"

Morgan Stanley named UnitedHealth Group a Top Pick on April 16, according to TipRanks, and set a $375 price target, pointing to improving Medicare Advantage dynamics as a key driver.

The firm's $375 price target implies about 16%upside from the stock's current share price of $323. The target was derived by applying an 18.3x valuation multiple on 2027's expected earnings per share of $20.45.

UnitedHealth's outlook got a real boost when the Centers for Medicare & Medicaid Services (CMS), the agency that sets reimbursement rates for Medicare Advantage plans, finalized the 2027 Medicare Advantage rate at 2.48%, up from just 0.09% in the advance notice.

That roughly 2.4% swing takes pressure off what was the biggest risk to the company's margin recovery.

This gives management more flexibility to reprice plans, adjust benefits, and improve member mix without eating as much underfunded cost risk. It also lowers the odds that 2026 and 2027 earnings get capped by weak government funding, just as margins are trying to recover.

The better funding backdrop also makes the path to about $17.75+in 2026 adjusted EPS more realistic, which is roughly in line with where analysts currently expect earnings to land for the fiscal year.

That means the recovery depends less on favorable medical cost trends and more on execution, cutting lower-quality members, tightening benefits, and pricing for profitability.

Morgan Stanley's view is that stronger rates make a controlled margin rebuild more achievable and reduce the risk of having to trade off earnings recovery for enrollment growth. It would show the reset is working if UnitedHealth can deliver a sub-86% medical loss ratio in early 2026 while holding EPS guidance above $17.75.

Optum Health weakness looks temporary

The second part of the story sits within Optum Health, UnitedHealth Group's care delivery and physician services segment. Morgan Stanley estimates that there was a roughly $600 millionprofit miss versus estimates in Q4 2025, but believes about 70% of that miss was one-time in nature.

A "structural" issue would imply lasting pressure on profitability, such as persistently higher costs or lower reimbursement rates, which would require a reset of long-term earnings expectations.

More Health Care:

• Is UnitedHealth a safe dividend stock after Medicare shock?
• CVS division enters Chapter 11 bankruptcy liquidation sale
• Novo Nordisk partners with OpenAI to speed drug discovery

However, a "one-time" or "non-recurring" issue suggests a temporary disruption, implying that the business can improve over time.

Morgan Stanley's estimate that about 70% of the shortfall is non-recurring points to its belief that Optum Health's division can recover from a temporarily bad quarter. Optum Health plays a central role in UnitedHealth's model by connecting the insurance business with care delivery.

Bloomberg/Getty Images

UnitedHealth's AI savings now carry real earnings weight

UnitedHealth's AI push is becoming a real earnings lever. Management has invested $1.5 billion and expects nearly $1 billion of operating cost reduction by 2026 across claims processing, coding, customer service, and care operations.

At this scale, even small efficiency gains can drive meaningful EPS upside because a large portion of the savings drops straight to the bottom line. It also gives the company a way to offset medical cost pressure without relying solely on better utilization or reimbursement.

This is where the advantage shows up. UnitedHealth has more ways to improve profits internally, so it can afford to drop lower-quality members and focus on higher-margin business.

Management is already cutting 1.3 to 1.4 million Medicare Advantage members to exit weaker cohorts, Fierce Healthcare noted. The move would be much harder for less diversified peers to pull off without hurting earnings.

AI is a big part of that advantage. The company is scaling more than 1,000 use cases, STAT reports, with tools such as Avery handling about 90% of inquiries. Optum pilots have also reduced denials by 80% and improved coding productivity by 73%.

If that efficiency holds, the earnings recovery becomes more durable. Morgan Stanley forecasts the company will see a medical loss ratio (MLR) of 85.3% in the first quarter, which could drive operating leverage for the business.

MLR measures the percentage of premium revenue spent on medical claims, so a lower ratio means the company is keeping more of each dollar as profit. Even small improvements at this level signal better cost control and improve margins.

What could drive UNH stock price higher

• Medicare Advantage funding has improved, setting up cleaner 2027 pricing and giving management more confidence to rebuild margins.
• Optum Health recovery could remove a major earnings drag as temporary disruptions fade.
• AI automation across claims and coding is lowering costs and boosting operating leverage.
• A sub-86% medical loss ratio in early 2026 would validate pricing and benefit changes.
• Holding adjusted EPS guidance above $17.75 would signal the recovery remains intact.

What could still go wrong for UNH

• Elevated outpatient and physician utilization could keep care costs rising faster than pricing.
• Optum Health issues may be more structural, limiting earnings recovery in the segment.
• Medicare Advantage mix could skew toward higher-acuity members, diluting margin gains.
• Repricing and benefit changes could hurt member retention.
• AI-driven cost savings may take longer to materialize, reducing near-term leverage.
• Regulatory scrutiny across managed care and pharmacy benefits remains an overhang.

What UNH investors need to know about earnings recovery

UnitedHealth's story is shifting from external pressure to internal execution. With Medicare Advantage rates improving, Optum Health issues looking more temporary, and AI starting to drive real cost savings, the path to earnings recovery is clearer.

If management delivers on margins and cost control, the stock has room to rerate higher as investors gain confidence in a more durable earnings base.

Related: Morgan Stanley has a bold message for Johnson & Johnson

The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

This story was originally published April 20, 2026 at 6:33 PM.